Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthritis

NCT01078116 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT01078116
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01078116 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthritis
Lead sponsor
Abbott
Phase
Observational
Overall status
Completed
Start date
November 30, 2007
Completion date
June 30, 2010
Enrollment
124 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis